Simply Wall St. via Yahoo
Shareholders in Spero Therapeutics (NASDAQ:SPRO) are in the red if they invested three years ago
Spero Therapeutics, Inc. (NASDAQ:SPRO) shareholders should be happy to see the share price up 23% in the last quarter. But only the myopic could ignore the astounding decline over three years ...
14 minutes ago